Bio-Path Holdings, Inc. (BPTH) Social Stream
BIO-PATH HOLDINGS INC (BPTH) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BIO-PATH HOLDINGS INC.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued August 15, 2023
The Trend in the Analyst Price Target
Over the past 25 months, BPTH's average price target has gone down $0.5.
BPTH reports an average of 1,318.83% for its upside potential over the past 151 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
BPTH Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 52 weeks, BPTH's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BPTH as an investment opportunity.
- BIO-PATH HOLDINGS INC's number of analysts covering the stock is higher than 5.86% of all US stocks.
- In the context of all US stocks, BIO-PATH HOLDINGS INC's upside potential (average analyst target price relative to current price) is higher than 590.84% of them.
- In terms of how BIO-PATH HOLDINGS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 47.74% of that group.
- In the context of Healthcare stocks, BIO-PATH HOLDINGS INC's average analyst price target is greater than 127.94% of them.
In the Pharmaceutical Products industry, ONTX, ADXS, and NWBO are the three stocks most similar to BIO-PATH HOLDINGS INC regarding the price target and analyst recommendation information presented here.
What is the outlook for BPTH? Use POWR Ratings for clearer insight into price direction.